Ignite Creation Date:
2024-05-06 @ 7:26 PM
Last Modification Date:
2024-10-26 @ 3:07 PM
Study NCT ID:
NCT06016738
Status:
RECRUITING
Last Update Posted:
2024-07-15
First Post:
2023-08-17
Brief Title:
OP-1250 Palazestrant vs Standard of Care for the Treatment of ERHER2- Advanced Breast Cancer
Sponsor:
Olema Pharmaceuticals Inc
Organization:
Olema Pharmaceuticals Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-11-16
Start Date Type:
ACTUAL
Primary Completion Date:
2026-06-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-09-30
Completion Date Type:
ESTIMATED
First Submit Date:
2023-08-17
First Submit QC Date:
August 29 2023
Study First Post Date:
2023-08-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-04
Last Update Post Date:
2024-07-15
Last Update Post Date Type:
ESTIMATED